Nasopharyngeal carcinoma, Immune checkpoint inhibitor, Immune-related adverse event, Immunotherapy, Meta-Analysis
Nasopharyngeal carcinoma, Immune checkpoint inhibitor, Immune-related adverse event, Immunotherapy, Meta-analysis